NEWS ABOUT THE CURE
Corporate Giving Reaches New Level
November 11, 2020
COVID-19 has caused so many typical office traditions and practices to be put on hold or even canceled altogether. With the holidays approaching, companies usually rely on the festive spirit to create comradery and team-building with such holiday favorites as white elephant exchanges, customer gift drop-offs, and company parties. This year, those practices may not be possible. But consider starting a new tradition. Dedicate the amount of money typically spent on parties or customer gifts to a…
Re-irradiation Side Effects and Considerations
November 2, 2020
DIPG.org
This article originally appeared on DIPG.org The Cure Starts Now sat down with Dr. Luke Pater, Associate Professor of Radiation Oncology at the University of Cincinnati Department of Radiation Oncology and Cincinnati Children’s Hospital, to discuss re-irradiation in terms of DIPG, DMG and medulloblastoma. Recently families facing progression of DIPG, DMG and Medulloblastoma have received recommendations to consider re-irradiation, can you explain what this involves? Re-irradiation for brain…
Translating Clinical Trials
October 16, 2020
Keith Desserich, Chairman of the Board at The Cure Starts Now, explains clinical trials – what they mean for cancer patients and how they work. Clinical trials are set up in phases, all designed to focus on an idea. We call these preclinical, or even translational research trials. They are designed to conduct testing on cancer cells in a test tube or mouse modeling. Ultimately you are trying to determine whether or not this idea, this concept, is actually going to work on cancer cells. From…
Cancer Research Fundraiser Goes Global & Exceeds Expectations by 700% Despite COVID-19
October 1, 2020
The Cure Starts Now’s "The Great Relay for Research" Raised Over $175,000 for Homerun Cure™ Cancer Research Cincinnati, OH | October 1, 2020 — The Cure Starts Now’s first annual “The Great Relay for Research” raised $179,105 for Homerun Cure™ cancer research surpassing their original goal by over 700 percent. With the cancellation of nearly 120 crucial spring and summer fundraising events due to the ongoing COVID-19 pandemic, the cancer research grant funding cycle for The Cure Starts Now is in…
Research Update: Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to DIPG
September 23, 2020
International Journal of Molecular Sciences
In 2017 Dr. Mara Vinci of the Bambino Gesù Children’s Hospital proposed an innovative study into investigating the role of DIPG-derived exosomes in tumor growth and invasion. This project was approved for funding by the DIPG/DMG Collaborative and The Cure Starts Now and here are his results: Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG Abstract The intratumor heterogeneity represents one of the most difficult…
Cincinnati Children's Announces Naming of Brain Tumor Center
September 23, 2020
https://www.cincinnatichildrens.org
The following article first appeared on cincinnatichildrens.org : Brain Tumor Center to be named after foundation that helps fight pediatric brain cancers Cincinnati Children’s Hospital Medical Center and The Cure Starts Now Foundation have been working together for more than 12 years to find ways to cure pediatric cancers. To recognize the collaboration, Cincinnati Children’s is announcing the naming of The Cure Starts Now Foundation Brain Tumor Center as part of a multimillion-dollar donation…
Graeter's Annual Cones for the Cure Campaign Raises Over $1 Million
September 14, 2020
Cones For The Cure Fundraising Campaign Has Raised Over $1 Million For Homerun Cure™ Cancer Research Since It Began In 2009 Cincinnati, OH | September 11, 2020 — The Cure Starts Now, in partnership with Graeter’s, today announced that the Cones for the Cure campaign has raised over $1 million in funds for Homerun Cure™ cancer research since its inception in 2009. The Cure Starts Now and Graeter’s have teamed up for the past 11 years to raise funds for crucial cancer research through the Cones…
Dr. Han Shen Discusses Overall Progress on his DIPG Research for The Cure Starts Now and the DIPG Collaborative
July 22, 2020
Dr. Han Shen, Westmead Institute for Medical Research, Australia Funded Project: Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas Funded Amount: $100,000 Dr. Shen provides an update on his recent project with the DIPG Collaborative and The Cure Starts Now and explains how it is providing clues to new treatment options for diffuse instrinsic pontine glioma. " DIPG is the most malignant childhood…
Research Update: New Links to Overcome Radiation Resistance in High-Grade Gliomas
July 14, 2020
Journal of Experimental & Clinical Cancer Research
In 2019 Dr. Han Shen of the University of Sydney proposed an innovative study into the impact of glycolysis, hypoxia, and circadian rhythm on radiotherapy treatment to high grade gliomas. Its impact would be to possibly refine how we administer radiation to patients in the hopes of improving one of the oldest and most effective treatments to brain cancers. This project was approved for funding by the DIPG/DMG Collaborative and The Cure Starts Now and here are his results: Hypoxia, metabolism…
Chris Jones: Beyond the Lab
July 13, 2020
Team Leader at The Institute of Cancer Research The Cure Starts Now recently sat down and had a conversation with leading DIPG researcher, Dr. Chris Jones: Why did you decide to focus your research on DIPG/DMG? "When I started my lab, the remit was to develop a research program in an area of unmet need in childhood cancer – nothing exemplifies this better than DIPG/DMG." What are some of the greatest advancements you have seen with DIPG/DMG research? "What is most remarkable is the way the…
Stay Up-to-date
DONATE FOR A CURE
100% of your donation goes direct to research after credit card fees. This means your money is used in the most efficient way possible. All of our grants fund specific research while making our researchers accountable to results and innovation.
DONATE